Focal Deletions of a Promoter Tether Activate the IRX3 Oncogene in T Cell Acute Lymphoblastic Leukemia
Preprint
Abstract
Oncogenes can be activated in cis through multiple mechanisms including enhancer hijacking events and noncoding mutations that create enhancers or promoters de novo . These paradigms have helped parse somatic variation of noncoding cancer genomes, thereby providing a rationale to identify noncanonical mechanisms of gene activation. Here we describe a novel mechanism of oncogene activation whereby focal copy number loss of an intronic element within the FTO gene leads to aberrant expression of IRX3 , an oncogene in T cell acute lymphoblastic leukemia (T-ALL). Loss of this CTCF bound element downstream to IRX3 (+224 kb) leads to enhancer hijack of an upstream developmentally active super-enhancer of the CRNDE long noncoding RNA (-644 kb). Unexpectedly, the CRNDE super-enhancer interacts with the IRX3 promoter with no transcriptional output until it is untethered from the FTO intronic site. We propose that ‘promoter tethering’ of oncogenes to inert regions of the genome is a previously unappreciated biological mechanism preventing tumorigenesis.Keywords
All Related Versions
- Published version: Blood, 144 (22), 2319.
This publication has 50 references indexed in Scilit:
- Differentiation block in acute myeloid leukemia regulated by intronic sequences of FTOiScience, 2023
- Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemiaCell Reports, 2023
- Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemiaThe Lancet Oncology, 2019
- Derepression of the Iroquois Homeodomain Transcription Factor Gene IRX3 Confers Differentiation Block in Acute LeukemiaCell Reports, 2018
- APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALLLeukemia, 2017
- A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in LeukemiaCell, 2014
- Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trialThe Lancet Oncology, 2013
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- High‐Throughput Real‐Time Quantitative Reverse Transcription PCRCurrent Protocols in Molecular Biology, 2006